Jay Research And Biotech India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 9.98 M
as on 07-12-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.00 M
as on 07-12-2024
- Revenue 39.71%
(FY 2020)
- Profit -131.46%
(FY 2020)
- Ebitda -202.51%
(FY 2020)
- Net Worth -37.65%
(FY 2020)
- Total Assets 4.86%
(FY 2020)
About Jay Research And Biotech India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.98 M.
The company has closed loans amounting to ₹2.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Praful Bafna and Prakash Bafna serve as directors at the Company.
- CIN/LLPIN
U17099PN2014PTC150726
- Company No.
150726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Jay Research And Biotech India Private Limited offer?
Jay Research And Biotech India Private Limited offers a wide range of products and services, including Fresh Fruits, Grapes, Pomegranates, Fertilizer, Bio Fertilizers, Cosmetics, Hair & Beauty Products, Hair Care Products, Pharmaceutical Services, Biotechnology Services, Bio Insecticides.
Who are the key members and board of directors at Jay Research And Biotech India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praful Bafna  | Director | 21-Feb-2014 | Current |
| Prakash Bafna | Director | 21-Feb-2014 | Current |
Financial Performance of Jay Research And Biotech India.
Jay Research And Biotech India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 39.71% increase. The company also saw a substantial fall in profitability, with a 131.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jay Research And Biotech India?
In 2021, Jay Research And Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ing Vysya Bank Limited Creation Date: 31 Dec 2014 | ₹2.00 M | Satisfied |
How Many Employees Work at Jay Research And Biotech India?
Jay Research And Biotech India has a workforce of 17 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jay Research And Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jay Research And Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
